Novo Nordisk aims to launch more than five blockbuster drugs by 2030, CEO says

​Novo ‌Nordisk aims to ​launch ‌more than five blockbuster drugs by ‌2030 and to deliver ‌more than 150 billion Danish ⁠crowns ($23 ​billion) ⁠in pipeline sales in ⁠2035, its CEO ​Mike Doustdar said ⁠at a Capital Markets ⁠Day ​in London.

($1 = 6.5096 ⁠Danish crowns)